Candidature YC de WonderTx
San Francisco
WonderTx a été sélectionné par Y Combinator dans le cadre du batch Summer 2026 en tant qu'entreprise Healthcare. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.
- Batch YC
- Summer 2026
- Secteur d'activité
- HealthcareTherapeutics
- Lieu
- San Francisco
- Taille de l'équipe
- 3
- Statut
- Active
- Lancé
- 2026
Fondateurs
Abraham HeifetsFounder/CEO
Ce que fait WonderTx
We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery. This should dramatically increase our probability of success. There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.
Candidature YC de WonderTx, reconstruite
Candidature Y Combinator
WonderTx, promotion Summer 2026. Les vraies questions de candidature, répondues à partir de données publiques.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
WonderTx
AI discovers pills to replace injectable drugs
We are building an AI-native biotech platform for oral drug discovery. Our tech designs new molecules that let you take, for example, insulin or Ozempic as a pill instead of a shot. Our models are trained to reason on targets that have worked in real humans, not just in animal models, removing the main risk in drug discovery. Drug discovery teams use our molecules to pursue first-in-class oral drugs for validated biology where there was no tractable starting point before.
We are based in San Francisco, CA, USA, and work remotely. After YC, we will remain based in San Francisco and remote.
San Francisco has a deep biotech and AI ecosystem, which helps on both the research and fundraising side. Our work is computational and experimental, so we work distributed, but physically close to the Bay Area network.
21 réponses supplémentaires dans la candidature complète
se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.
Questions fréquemment posées
Est-ce la vraie candidature YC de WonderTx ?
Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de WonderTx (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme WonderTx se présenterait à YC, pas le texte qu'ils ont soumis.
À quel batch YC WonderTx appartenait-il ?
WonderTx faisait partie du batch Summer 2026 de Y Combinator.
Qui a fondé WonderTx ?
WonderTx a été fondé par Abraham Heifets.
Que fait WonderTx ?
Extrapolative AI to unlock First-in-Class drugs
Comment lire la candidature complète reconstruite ?
Créez un compte Round Funded gratuit. La version complète de la candidature de WonderTx en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.
Plus de startups YC comme WonderTx
